Chargement en cours...
Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis
High doses of rifampin may help patients with tuberculous meningitis (TBM) to survive. Pharmacokinetic pharmacodynamic evaluations suggested that rifampin doses higher than 13 mg/kg given intravenously or 20 mg/kg given orally (as previously studied) are warranted to maximize treatment response. In...
Enregistré dans:
| Publié dans: | Antimicrob Agents Chemother |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256787/ https://ncbi.nlm.nih.gov/pubmed/30224533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01014-18 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|